INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

AURAAura Biosciences, Inc.

CIK 0001501796

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score13
Connections6with evidence

AURA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
EA
Elazzouzi AmySVP, Finance & PAO
AURAAura Biosciences, Inc.
Grant or award
A—
23.5K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Kratz EricaChief Reg. & Quality Officer · Sep 1, 2026
  • ← Insider ofevidence
    Abu-Absi SusanChief Operating Officer · Sep 1, 2026
  • ← Insider ofevidence
    Elazzouzi AmySVP, Finance & PAO · Sep 1, 2026
9
EA
Elazzouzi AmySVP, Finance & PAO
AURAAura Biosciences, Inc.
Grant or award
A
—
46.5K sh
Sep 1, 2026
Sep 1, 2026
traded Sep 1, 2026
+0d
SEC FORM 4

Evidence

13
HJ
Hopkins Janet JillChief Medical Officer
AURAAura Biosciences, Inc.
Grant or award
A—
58.9K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

9
PJ
Person JulieChief People Officer
AURAAura Biosciences, Inc.
Grant or award
A—
107.6K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

9
PJ
Person JulieChief People Officer
AURAAura Biosciences, Inc.
Grant or award
A—
212.4K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

9
AS
Abu-Absi SusanChief Operating Officer
AURAAura Biosciences, Inc.
Grant or award
A—
265.5K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

9
AS
Abu-Absi SusanChief Operating Officer
AURAAura Biosciences, Inc.
Grant or award
A—
134.5K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

9
HJ
Hopkins Janet JillChief Medical Officer
AURAAura Biosciences, Inc.
Grant or award
A—
116.2K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

9
KE
Kratz EricaChief Reg. & Quality Officer
AURAAura Biosciences, Inc.
Grant or award
A—
100.9K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

9
KE
Kratz EricaChief Reg. & Quality Officer
AURAAura Biosciences, Inc.
Grant or award
A—
199.1K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Hopkins Janet JillChief Medical Officer · Sep 1, 2026
  • ← Insider ofevidence
    Person JulieChief People Officer · Sep 1, 2026